Autoimmune hemolytic anemia (AIHA) is caused by antibody-mediated destruction of erythrocytes. AIHA may be primary or secondary to other underlying autoimmune conditions, immunodeficiencies, rheumatologic diseases, infections, or malignancies. The adoles
autoimmune thrombocytopenia, fetal loss, and other clinical features, including transient ischemic attacks, amaurosis fugax, Coombs-positive hemolytic anemia, and livedo reticularis.
AIHA, autoimmune hemolytic anemia; CTCs, corticosteroids; Hb, hemoglobin; LDH, lactate dehydrogenase; RBCs, red blood cells; RTX, rituximab. AIHA secondary to COVID-19 vaccination was managed with immunosuppressive agents, especially corticosteroids and occasionally rituximab [103,106,107]. A young ...